hearing loss begins childhood deafness ensues 10 15 years gene editing gene therapy not thing involves insertion good copy gene overcome deficiency copy patient born clinical trial begun hearing loss aims regenerate hair cells patients acquired hearing loss injecting new gene kickstarts supporting cells hair cells says lawrence lustig chair otolaryngology columbia university medical center sites involved trial approach not work dominant mutations like mutation says lustig not grow new hair cells bad genetic background kill hair cells food drug administration approved december 19 gene therapy rare inherited form blindness treatment cost $ 1 million technology like crispr cas9 different